AOD-9604 cycle length typically runs 8 to 12 weeks, with some research protocols extending to 24 weeks. Learn dosing, timing, and safety factors.
AOD-9604 cycle length typically runs 8 to 12 weeks in most research protocols, with a smaller number of studies continuing for up to 24 weeks. AOD-9604 is a synthetic fragment of human growth hormone (hGH 176-191), and it is not FDA-approved for human use in the United States. That means cycle length is a research variable rather than a prescribed schedule, and individual results vary widely.
How Long Do Most AOD-9604 Cycles Run?
Human trials of AOD-9604 have used treatment windows as short as 4 weeks and as long as 6 months. Most people who follow community protocols land on 8 to 12 weeks because that range captures the fat-metabolism effects reported in short-term studies without extending exposure indefinitely.
A typical structure looks like this:
- First cycle: 8 weeks on, 4 weeks off.
- Standard cycle: 12 weeks on, 4 to 6 weeks off.
- Extended cycle: 16 to 24 weeks, usually with periodic bloodwork.
Discussion of aod 9604 cycle length often centers on how quickly results appear. In most anecdotal reports, changes are noticed between weeks 4 and 8, which is one reason shorter cycles stay popular.
Several practical factors push most users toward a 12-week ceiling:
- Fat-loss signals in early trials appeared within the first 4 to 8 weeks.
- Longer exposure did not clearly produce proportionally larger results.
- Any growth-hormone-related peptide carries a theoretical risk of hormonal adaptation.
- Breaks make it easier to tell whether the peptide is doing anything at all.
No official body publishes a recommended AOD-9604 cycle. The 12-week figure is a convention that balances enough time to measure a change against the desire to limit continuous exposure to an unapproved compound.
Dosing and Timing Inside a Cycle
Cycle length only makes sense next to the dose used. Early human trials used 1 mg per day, while most self-directed users report far smaller amounts. If you are mapping out aod 9604 dosage, the common starting point in online communities is 300 mcg injected subcutaneously once daily.
Timing is usually built around fasting. Many people inject in the morning or before fasted cardio because the peptide is thought to mimic part of hGH's fat-metabolizing activity, and food intake near the injection is often avoided to keep the absorption window clean.
The process of aod 9604 reconstitution with bacteriostatic water is standard, and the mixed solution is typically refrigerated and used within a few weeks. Poor handling or inconsistent measurement can make a well-planned cycle look like it failed when the real problem was technique.
What Changes in a Longer Cycle
Extending past 12 weeks mainly changes three things: total exposure, cost, and the amount of monitoring needed. Someone running 16 to 24 weeks will usually check bloodwork at the midpoint rather than waiting until the end.
AOD-9604 Compared With Other Fat-Loss Options
Cycle length decisions often depend on what the peptide is being weighed against. The table below compares common options.
| Compound | Typical cycle length | Typical dose | Regulatory status |
|---|---|---|---|
| AOD-9604 | 8–12 weeks | 300 mcg–1 mg daily | Not FDA-approved |
| Tesamorelin | 12–26 weeks | 2 mg daily | FDA-approved for HIV-related visceral fat |
| MOTS-c | 4–8 weeks | 5–10 mg per week | Research only |
| Tirzepatide | Ongoing | 2.5–15 mg weekly | FDA-approved; requires a prescription |
When people compare aod 9604 vs tesamorelin, the clearest difference is regulatory status: tesamorelin is a prescription drug approved for a specific condition, while AOD-9604 has no approved human indication. Comparisons to mitochondrial peptides like MOTS-c usually come down to cycle structure, since MOTS-c is often run in much shorter blocks.
Side Effects and Safety Considerations
Human trials of AOD-9604 reported few serious adverse events, but that does not make the peptide risk-free. Reported issues include injection-site irritation, headache, and mild gastrointestinal discomfort.
Longer cycles mean longer exposure, and data beyond 24 weeks is thin. Weighing aod 9604 benefits and side effects should also account for the fact that the compound is sold as a research chemical, so purity and labeling vary between suppliers.
Anyone using AOD-9604 should talk with a healthcare professional, particularly if they take medication for diabetes, thyroid conditions, or hormone therapy. Bloodwork before, during, and after a cycle is the most reliable way to catch problems early.
Signs That a Cycle Should End Early
Stop and seek medical advice if you notice persistent injection-site swelling, unusual fatigue, rapid heartbeat, or any reaction that does not resolve within a few days. A cycle can always be restarted later; a health problem that is ignored rarely improves on its own.
How Long Should the Break Between Cycles Be?
Most protocols recommend an off period equal to roughly half the time spent on, so a 12-week cycle is followed by 4 to 6 weeks off. The break lets the body return to baseline and shows whether results hold without the peptide.
No human data defines an ideal off period. A practical rule is to stay off at least until any side effects resolve and bloodwork returns to normal.
Bottom Line on AOD-9604 Cycle Length
An 8-to-12-week cycle is the most defensible choice for AOD-9604 based on available research, and extending beyond 24 weeks means going past the published data. Because the peptide is not approved for human use, dosing accuracy, product quality, and monitoring matter as much as cycle length itself.
Anyone considering AOD-9604 should treat it as an unapproved research compound and consult a healthcare professional before starting.
Frequently Asked Questions
How long should an AOD-9604 cycle last?
Most research and community protocols run 8 to 12 weeks, followed by 4 to 6 weeks off. Some people extend to 16 or 24 weeks, but human data beyond 24 weeks is limited. AOD-9604 is not FDA-approved for human use in the United States.
Do you need to take a break between AOD-9604 cycles?
Most protocols include an off period of roughly half the cycle length, so about 4 to 6 weeks after a 12-week cycle. The break helps separate the peptide's effects from diet and training changes and limits continuous exposure. No human study establishes an optimal off period.
Is AOD-9604 safe, and what are the side effects?
Human trials reported few serious adverse events, with injection-site irritation, headache, and mild stomach upset being the most common complaints. Because AOD-9604 is sold as a research chemical, purity and dosing accuracy are not guaranteed. Talk to a healthcare professional before using it.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.